4EM-21109-09912
3 vaccinations
7 coded responses
13 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 534 / WI
- Registered
- 2021-07-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Dose 1 — Pfizer-BioNTech
-
2021-04-24
Dose 2 — Pfizer-BioNTech
-
2021-07-25
Registered in v-safe
- 2021-07-25
- 2021-10-23
-
2021-11-03
Dose 3 — Pfizer-BioNTech
-
2021-11-04
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain, Pre-existing disease, Rhinorrhoea — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Sore throat & runny nose developed later in day today. Health condition: Lupus SLE & chronic migraineMedDRA releases: 2024-11 · check-in free text available
-
2021-11-05
Survey response — days 1–6 daily, dose 3MedDRA: Adverse reaction — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Symptoms improved significantly throughout dayMedDRA releases: 2024-11 · check-in free text available
-
2021-11-06
Survey response — days 1–6 daily, dose 3MedDRA: Pre-existing disease — Feeling: Good · Site: Pain, Redness · Fatigue or tiredness, DiarrheaFree text: Health condition: Lupus SLEMedDRA releases: 2024-11 · check-in free text available
- 2021-11-07
- 2021-11-20
- 2021-11-24
-
2021-12-01
Survey response — day 28, dose 3MedDRA: Cough, Exposure to SARS-CoV-2, Gastrointestinal disorder, Headache, Myalgia, Oropharyngeal pain, Parosmia, Pyrexia, Rash — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever, cough, sore throat, phantom smells, headache, muscle aches, intestinal issues, rash. Exposure to positive COVID19 case; my test was negative though.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-10
Survey response — day 35, dose 3MedDRA: Fatigue, Fibromyalgia, Myalgia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Increased fatigue and muscle pain. Diagnosed with fibromyalgia.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-10
Report sent to call center — day 35, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-14
-
2021-12-15
Survey response — day 42, dose 3MedDRA: Cough, Dizziness, Exposure to SARS-CoV-2, Headache, Hypoaesthesia, Myalgia, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Dizzy, cough, runny nose, headache, muscle aches, numbness, cough. 3 people in my home have tested positive for COVID. Probably have it too.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-05
-
2022-11-06
Survey response — 12 months, dose 3MedDRA: Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Chronic hives of unknown originMedDRA releases: 2024-11 · check-in free text available
-
2022-11-06
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-07
- 2022-11-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Pfizer-BioNTech | No |
| 2 | 2021-04-24 | Pfizer-BioNTech | No |
| 3 | 2021-11-03 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Sore throat & runny nose developed later in day today. Health condition: Lupus SLE & chronic migraine
Systemic reaction (other): Symptoms improved significantly throughout day
Systemic reaction (other): Health condition: Lupus SLE
Release 10 — day 28, dose 3
Symptoms: Fever, cough, sore throat, phantom smells, headache, muscle aches, intestinal issues, rash. Exposure to positive COVID19 case; my test was negative though.
Release 10 — day 35, dose 3
Symptoms: Increased fatigue and muscle pain. Diagnosed with fibromyalgia.
Release 10 — day 42, dose 3
Symptoms: Dizzy, cough, runny nose, headache, muscle aches, numbness, cough. 3 people in my home have tested positive for COVID. Probably have it too.
Release 12 — 12 months, dose 3
Symptoms: Chronic hives of unknown origin
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Fibromyalgia | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypoaesthesia | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Parosmia | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Adverse reaction | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release